Muscle growth and recovery are among the most heavily researched applications in the peptide space, largely because several well-studied compounds intersect with tissue repair and growth hormone signaling pathways. Below is an overview of what researchers are actively studying in this area.

Compounds commonly studied for muscle-related research

• BPC-157 — A synthetic peptide derived from a protein found in gastric juice, studied for its role in accelerating tissue repair, including muscle, tendon, and ligament healing in animal models.
• TB-500 (Thymosin Beta-4) — Studied for its involvement in cell migration and tissue regeneration, with particular research interest in recovery from muscular injury.
• CJC-1295 — A growth hormone-releasing hormone (GHRH) analog studied for its effect on growth hormone secretion pathways relevant to lean mass and recovery research.
• Ipamorelin — A selective growth hormone secretagogue, often studied alongside CJC-1295, with research interest in its more targeted GH-release profile compared to older secretagogues.
• IGF-1 LR3 — A long-acting analog of insulin-like growth factor 1, studied for its extended half-life compared to native IGF-1 and its role in muscle hypertrophy and satellite cell activation research.
• PEG-MGF (PEGylated Mechano Growth Factor) — A modified splice variant of IGF-1 studied for its localized role in triggering satellite cell activation following mechanical tissue stress.
• MK-677 (Ibutamoren) — An orally active, non-peptide growth hormone secretagogue studied for sustained GH and IGF-1 elevation without the injection frequency peptide-based secretagogues require.
• GHRP-2 — A growth hormone-releasing peptide studied for potent GH stimulation alongside moderate appetite-related signaling.
• GHRP-6 — An earlier-generation growth hormone-releasing peptide studied for GH secretion, with a more pronounced effect on appetite stimulation pathways than GHRP-2.
• Hexarelin — Among the most potent GHRPs studied, researched for GH release as well as separate research interest in cardioprotective signaling pathways.
• DSIP (Delta Sleep-Inducing Peptide) — Studied for its association with sleep architecture; often included in recovery-focused research given the relationship between deep sleep and endogenous growth hormone release.

What the research generally focuses on

• Mechanisms of tissue repair following induced injury in animal models
• Growth hormone axis signaling and downstream effects on lean tissue
• Recovery timelines when compounds are studied in combination versus in isolation
• Satellite cell activation and localized muscle tissue signaling
• Sleep architecture’s relationship to endogenous GH release

Before you start

If you’re new to this category, start with our What Are Peptides? overview and Peptide Stability & Handling in Research Settings guide — proper handling matters just as much as compound selection for reliable research results.

This content is provided for research and informational purposes only. Agape Compounds products are not intended for human or animal consumption.